Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Apr 18:15:1414812.
doi: 10.3389/fimmu.2024.1414812. eCollection 2024.

Editorial: Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performance

Marta Barisa  1 , Daniel Abate-Daga  2 , Jonathan Fisher  1
Affiliations
Editorial

Editorial: Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performance

Marta Barisa et al. Front Immunol. .
No abstract available

Keywords: BiTe; CAR-T; checkpoint blockade (ICB) therapy; immunotherapy; oncology; γδT cell.

PubMed Disclaimer

Conflict of interest statement

MB, JF, and DA-D are all inventors on patents that pertain to gene-modified cellular immunotherapy development and use. DA-D is a member of the scientific advisory board of Anixa Biosciences and receives or has received research funding from Celgene/BMS, bluebird bio, and Intellia Therapeutics. MB is a member of the scientific advisory board of LAVA Therapeutics.

Comment on

  • Editorial on the Research Topic Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performance

Similar articles

See all similar articles

References

    1. Mensurado S, Blanco-Domínguez R, Silva-Santos B. The emerging roles of γδ T cells in cancer immunotherapy. Nat Rev Clin Oncol. (2023) 20(3):178–191. doi: 10.1038/s41571-022-00722-1 - DOI - PubMed
    1. Dolgin E. Unconventional γδ T cells ‘the new black’ in cancer therapy. Nat Biotechnol. (2022) 40:805–8. doi: 10.1038/s41587-022-01363-6 - DOI - PubMed
    1. Labanieh L, Mackall CL. CAR immune cells: design principles, resistance and the next generation. Nature. (2023) 614:635–48. doi: 10.1038/s41586-023-05707-3 - DOI - PubMed
    1. Harrison RP, Zylberberg E, Ellison S, Levine BL. Chimeric antigen receptor–T cell therapy manufacturing: modelling the effect of offshore production on aggregate cost of goods. Cytotherapy. (2019) 21:224–33. doi: 10.1016/j.jcyt.2019.01.003 - DOI - PubMed
    1. Willcox BE, Willcox CR. γδ TCR ligands: the quest to solve a 500-million-year-old mystery. Nat Immunol. (2019) 20:121–8. doi: 10.1038/s41590-018-0304-y - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources